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ABSTRACT 
 
Yersinia enterocolitica is a foodborne pathogen 
which is primarily responsible for gastrointestinal 
infections. The presence of the virulence genes in    
Y. enterocolitica strains isolated from children and 
antimicrobial resistance was studied in this work. 
The PCR, biotyping and disc diffusion method were 
used for analysis of Y. enterocolitica strains. Most of 
Y. enterocolitica strains belonged to biotype 4 and 
all carried ail, myfA and ystaA genes. Most of them 
also had the plasmid yadA gene. These genes were 
also detected in the strains of biotype 2, while in the 
two strains of biotype 1A only myfA gene was 
found. The blaA gene was present in all the strains 
of biotype 4 and 2, while blaB in the strains of 
biotype 2 and in some of biotype 4 strains. The 
presence of β-lactamase genes in Y. enterocolitica 
was not detected in biotype 1A. All strains were 
resistant to ampicillin, 76.2% and 47.6% were 
resistant to ticarcillin and piperacillin, respectively. 
Two strains (9.5%) were resistant to amoxicillin/ 
clavulanic acid and aztreonam, three (14.3%) to 
chloramphenicol, four (19%) to amikacin and 
trimethoprim/sulfamethoxazole, six (28.6%) to 
gentamicin. A few strains of Y. enterocolitica were 
multidrug resistant. The Y. enterocolitica strains 
isolated from the faeces of children suffering from 
diarrhea carried virulence genes and some of them 
were resistant to antibiotics used in extra-intestinal 
yersiniosis treatment.  
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1. INTRODUCTION 
 
 Yersinia enterocolitica is an important human 
pathogen with the global distribution and a variety 
of clinical disorders such as enteritidis, enteroco-
litis, gastroeneritidis, mesenteric lymphadenitis and 
others [1]. Yersiniosis is a zoonotic foodborne 
bacterial disease with high public health relevance. 
In Europe it is the third most common bacterial 
enteric disease after campylobacteriosis and salmo-
nellosis [2]. Animals such as pigs, rodents, sheep, 
goats, cattle, horses are reservoirs of Y. entero-
colitica. Pigs are a major reservoir for human 
pathogenic strains, especially for bioserotype 4/O3 
[3]. This microorganism is considered an important 
foodborne pathogen including strains of diverse 
pathogenicity. Infections are most often acquired 
through ingestion of contaminated pork, milk,         
dairy foods, vegetables and contaminated drinking 
water or pet animal contact [4, 5]. The pathogenic  
Y. enterocolitica strains were also isolated from 
waste water samples in Turkey [6] or from river water 
in Poland [7]. Y. enterocolitica is rarely transmitted 
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through contaminated blood during transfusion [8]. 
The species Y. enterocolitica is divided into six 
biotypes. Strains of biotype 1A are generally regar-
ded as nonpathogenic, whereas strains of biotypes 
1B, 2, 3, 4, and 5 carry a virulence plasmid pYV. 
This plasmid encodes type III secretion system and 
the outer membrane protein YadA (Yersinia adhesin 
A). YadA was found to play multiple functions             
in pathogenesis because it protects bacterial cells 
against antibacterial activity of complement and 
mediates specific binding of Y. enterocolitica to 
laminin, collagen and cellular fibronectin [9]. The 
chromosomal Y. enterocolitica virulence markers 
are ail, ystA and myfA genes. The ail gene encodes a 
small outer membrane protein (Ail adhesin), which 
promotes adhesion of Y. enterocolitica and invasion 
of epithelial cells. The ystA gene encodes entero-
toxin YstA, which activates the guanylate cyclase 
that leads to the increased cGMP level. High level of 
cGMP causes fluid accumulation in the intestine 
[10]. The major subunit of antigen Myf is encoded 
by the myfA gene. This fibrillar structure promotes 
the colonization of the intestine by yersiniae [11]. 
Biotyping is used for clinical and epidemiological 
classification of Y. enterocolitica, but the hetero-
genous nature of Y. enterocolitica, including diffe-
rences in virulence, requires genotyping methods 
and this may be a novel way of pathogenic 
characterization of this microorganism.  
 The aim of this study was the description of  
Y. enterocolitica strains isolated from the faeces of 
children suffering from diarrhea by using PCR 
assays for the detection of some virulence genes  
and in vitro evaluation of antibiotic sensitivity                
of this pathogen. The presence of genes coding              
β-lactamases was also detected in the genome of               
Y. enterocolitica strains.  
 
2. MATERIALS AND METHODS 
 
2.1. Strains  
 
 Twenty one Y. enterocolitica strains were 
isolated from the faeces of children suffering from 
diarrhea. The strains were isolated from children 
treated in different hospitals and outpatients in 
Warsaw (Poland) over the period 2009-2015. The 
identification of the strains was performed with the 
VITEK GNI card system (VITEK 2 instrument, 
version 4.01, bioMérieux). Biotyping of Y. entero-
colitica strains was performed according to Wauters 
et al. [12]. The strains were stored at -70°C in Brain 
Heart Infusion (BHI) Broth (BHI; BBL, Becton 
Dickinson) containing 15% glycerol.  
 
2.2. Antibiotic susceptibility testing 
 
 The susceptibility of the strains was tested 
with a disc diffusion method using the following 
antibiotic discs (Oxoid, Basingstoke, UK): ampi-
cillin (25 µg), amoxicillin/clavulanic acid (20/10 
µg), cefepime (30 µg), cefotaxime (30 µg), cefuro-
xime (30 µg), ceftazidime (30 µg), ceftriaxone (30 
µg), gentamicin (10 µg), imipenem (10 µg), norflo-
xacin (10 µg), piperacillin (100 µg), ticarcillin (75 
µg), tobramycin (10 µg), aztreonam (30 µg), cipro-
floxacin (5 µg), amikacin (30 µg), chloramphenicol 
(30 µg) and trimethoprim/sulfamethoxazole (1.25/ 
23.75 µg). The results were recorded by measuring 
the inhibition zones and scored as susceptible, 
intermediately susceptible, and resistant, according 
to the Clinical and Laboratory Standards Institute 
[13]. 
 
2.3. DNA isolation 
 
 Genomic DNA was isolated from Y. entero-
colitica strains by using the Genomic DNA PrepPlus 
(A&A Biotechnology, Poland), according to the 
manufacturer’s protocol. 2.5 µl of the total extracted 
material from each test sample was used as a 
template DNA for PCR application.  
 
2.4. Primers and PCR conditions 
 The primers specific for the ail, ystA, myfA, 
yadA, blaA, blaB and 16S rRNA genes of Y. entero-
colitica, synthesized at DNA-Gdańsk (Gdańsk, 
Poland), are listed in Table 1. The duplex PCR            
for ail and ystaA genes was performed in a 25-µl 
volume containing 2.5 µl of DNA template, 1×PCR 
buffer, 0.2 mM each dATP, dCTP, dGTP, and dTTP 
(Fermentas, Lithuania), the ail-specific primers and 
ystA-specific primers at 50 nM, with 1 U of RedTag 
Genomic DNA polymerase (Sigma-Aldrich, Ger-
many). The amplification was carried out under the 
following conditions: initial denaturation (94°C, 3 
min), followed by 30 subsequent cycles consisting 
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of denaturation (94°C, 1 min), primer annealing 
(52°C, 1.5 min), extension (72°C, 1.5 min), and final 
extension (72°C, 10 min).  
 The duplex PCR for blaA and blaB genes was 
also performed in a 25 µl volume containing 2.5 µl 
of DNA template, 1 x PCR buffer, 200 µM of           
each: dATP, dCTP, dGTP, and dTTP (Fermentas, 
Lithuania), 100 nM of the blaA and the blaB pair of 
specific primers, and 1U of RedTag Genomic DNA 
polymerase (Sigma-Aldrich, Germany). The ampli-
fication was carried out under the following 
conditions: initial denaturation at 95°C for 5 min, 35 
cycles of denaturation at 95°C for 0.5 min, primer 
annealing at 50°C for 0.5 min and extension at 72°C 
for 1 min. A 5 min extension at 72°C was performed 
at the end of the final cycle. The monoplex PCR for 
myfA gene and yadA gene as described earlier [19] 
and monoplex PCR for the 16S rRNA gene for 
species identification as described by Wannet et al. 
[18] were also performed.  
 The amplifications were carried out in the 
Multi Gene II thermal cycler (Labnet International, 
Inc., USA). The PCR products were analysed by 
electrophoresis in 1.5% agarose gels stained with 
ethidium bromide. Molecular size markers (Sigma-
Aldrich) were also run for product size verification. 
The gel was electrophoresed in 2 × Tris-borate 
buffer at 70 V for 1.5 h.  
 
 
Table 1. Oligonucleotide primers used in the study. 
Primers Sequence (5' → 3') Amplicon length (bp) References 
ail-a (F) TGGTTATGCGCAAAGCCATGT 
356 [14] 
ail-b (R) TGGAAGTGGGTTGAATTGCA 
ystA-a (F) GTCTTCATTTGGAGGATTCGGC 
134 [14] 
ystA-b (R) AATCACTACTGACTTCGGCTGG 
myfA-1 (F) CAGATA CAC CTG CCT TCC ATCT 
272 [15] 
myfA-2  (R) CTCGACATATTCCTCAACACGC 
yadA-1 (F) TAAGATCAGTGTCTCTGCGGCA 
747 [16] 
yadA-2 (R) TAGTTATTTGCGATCCCTAGCAC 
blaA-1 (F) 
blaA-2 (R) 
AAATGCGCTACCGGCTTCAG 
AGTGGTGGTATCACGTGGGT 439 [17] 
blaB-1 (F) 
blaB-2 (R) 
CCCACTTTATACCTTGGCACAAA 
GAACATATCTCCTGCCTGGAAAT 781 [17] 
16S rRNA-Y1 (F) 
16S rRNA-Y2 (R) 
AATACCGCATAACGTCTTCG 
CTTCTTCTGCGAGTAACGTC 330 [18] 
 
 
3. RESULTS 
 
 Biotype 4 was most numerously represented 
by 71.4% of Y. enterocolitica strains. A small group 
included strains of biotype 2 and biotype 1A (Table 
2).  
 The 330 bp fragment, specific amplification 
product for the Y. enterocolitica 16S rRNA gene, 
was obtained in case of all the strains (Fig. 1A). A 
duplex PCR was used for the detection of the ystA-
specific PCR product of 134 bp and the ail-specific 
product of 356 bp (Fig. 1B). These genes were 
present in all the strains of 4 and 2 biotype (Table 
2). The yadA-specific amplification product of 747 
bp was detected in all the strains of biotype 2 and 
the majority of strains belonging to biotype 4 
(86.6%) (Fig. 1C). The myfA-specific PCR product 
of 272 bp (Fig. 1D) was detected in all the             
strains which belonged to different biotypes. Using 
multiplex PCR, 439 bp fragment for blaA gene in all 
the strains of biotype 4 and 2 was obtained (Fig. 
1E). The amplification products for blaB (827 bp) 
were detected in all strains of biotype 2, and only              
in eight strains of biotype 4. The presence of                   
β-lactamase genes in Y. enterocolitica was not 
detected in biotype 1A.  
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Table 2. Virulence genes and resistance profiles of Y. enterocolitica strains from the faeces of children with intestinal 
yersiniosis. Bt - biotype, AMP - ampicillin, TIC - ticarcillin, AMC - amoxicillin plus clavulanic acid, PIP - piperacillin, 
GM - gentamicin, AN - amicacin, C - chloramphenicol, SXT - trimethoprim/sulfamethoxazole, ATM - aztreonam,                   
* - multidrug resistance strains, „-„ no amplification. 
Strains Year Bt Results of PCR for: Resistance profile 
   ail yadA myfA ystA blaA blaB  
9996 2009 2 + + + + + + AMP/TIC/AMC 
6068 2010 1A - - + - - - AMP/PIP 
10743 2010 4 + + + + + + AMP/TIC/GM 
15869 2010 4 + + + + + + AMP/PIP/TIC 
6528 2010 4 + - + + + + AMP/AN/C/SXT* 
6701 2010 4 + - + + + + AMP/TIC 
7217 2012 2 + + + + + + AMP/PIP/TIC/SXT 
20179 2013 2 + + + + + + AMP/TIC/C/SXT* 
10510 2013 1A - - + - - - AMP/PIP/TIC/SXT 
15395 2013 4 + + + + + + AMP/GM 
26530 2014 4 + + + + + + AMP/PIP/AN/GN 
13004 2015 4 + + + + + - AMP/PIP/TIC 
2 2015 4 + + + + + - AMP/TIC 
13571 2015 4 + + + + + - AMP/TIC/ATM/AMC 
601 2015 4 + + + + + - AMP/TIC 
1 2015 4 + + + + + - AMP, TIC 
158 2015 4 + + + + + - AMP/TIC 
450/6 2015 2 + + + + + + AMP/PIP/TIC/GM 
448/7 2015 4 + + + + + + AMP/PIP/ATM/AN/GN/C* 
511/8 2015 4 + + + + + + AMP/PIP/TIC/AN/GM 
301/3 2015 4 + + + + + - AMP/TIC 
 
 
 The Y. enterocolitica strains showed high 
resistance to antibiotics belonging to penicillin 
group because all the strains were resistant to 
ampicillin, above 76% of the strains were resistant 
to ticarcillin and about 48% were resistant to 
piperacillin. Additionally, two strains (9.5%) were 
resistant to amoxicillin/clavulanic acid. About 29% 
and 19% of the strains were resistant to gentamicin 
and amikacin, respectively. Moreover, two strains 
(9.5%) were resistant to aztreonam. In case of 
chloramphenicol, 14.3% of the strains showed 
resistance and 19% of the strains were resistant             
to trimethoprim/sulfamethoxazole. All the strains 
were sensitive to cephalosporins, fluoroquinolones, 
imipenem and tobramycin (Fig. 2). Among the 
tested Y. enterocolitica, three strains were multidrug 
resistant. Two strains of biotype 4 showed resistance 
to antimicrobial agents from four various chemical 
groups and one strain of biotype 2 was resistant to 
antimicrobial agents belonging to three different 
chemical groups (Table 2).  
 
4. DISCUSSION 
 
 Y. enterocolitica is an important foodborne 
pathogen which is primarily responsible for 
gastrointestinal infections in young children. The 
incidence of Y. enterocolitica infection is highest 
among children under 5 years of age [20].  
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A B 
     M       1        2         3        4        5 
 
      M       1        2        3        4       5 
 
C D 
    M       1        2        3         4         5 
 
      M       1        2        3       4        5 
 
E  
    M        1        2         3        4         5 
 
 
Figure 1. Electrophoresis in 1.5% agarose gel PCR products obtained by using specific primers for 16S rRNA gene (A), 
ail and ystA genes (B), yadA gene (C), myfA (D) and blaA and blaB genes (E). 
 
 
 
Figure 2. Antimicrobial resistance of Y. enterocolitica 
strains isolated from the faeces of humans with intestinal 
yersiniosis. AMC - amoxicillin/clavulanic acid, SXT - 
trimethoprim/sulfamethoxazole. 
 The high incidence of Y. enterocolitica 
infections in this age group, compared with other 
gastrointestinal infections, such as salmonellosis and 
campylobacteriosis, may result from eating food 
prepared from raw pork products, use of baby's 
dummy or contact with domestic animals, such as 
dogs and cats [21]. In addition, factors that may 
contribute to the high incidence of Y. enterocolitica 
infection in young children include an increased rate 
of exposure to this pathogen as a result of fecal-oral 
contamination, predisposition to infection due to 
immature immune system [22] and higher frequency 
of testing stool samples in case of children when 
affected [23]. In our research we investigated                  
Y. enterocolitica strains isolated from the faeces         
of children suffering from diarrhea. Among them, 
strains belonging to biotype 4 carrying the ail, myfA 
and ystaA genes predominated. Most of them had 
also the plasmid gene yadA, confirming the presence 
of the plasmid pYV. These results demonstrated the 
pathogenic potential of the investigated strains to 
susceptible hosts. Our results are similar to those 
 330 bp   
(16SrRNA) 
356 bp (ail) 
134 bp (ystA) 
747 bp (yadA) 
272 bp (myfA) 
 827 bp (blaB) 
 439 bp (blaA) 
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obtained by other authors that also showed that 
strains belonging to biotype 4 are responsible for 
most infections caused by Y. enterocolitca in Europe 
[4, 20]. The strains of biotype 2 are rarely isola-    
ted from humans. The pathogenic potential of the 
biotype 2 strains examined in this study was 
highlighted by the occurrence of the virulence 
markers investigated. Similar results were obtained 
by Frazão and Falcão [24], who also studied strains 
of Y. enterocolitica biotype 2.  
 Uncomplicated course of yersiniosis usually 
does not require the use of antibiotics. However, 
some cases of yersiniosis, such as sepsis, focal 
extra-intestinal infection or infection in immune-
compromised patients require antimicrobial treat-
ment. Y. enterocolitica strains are β-lactamase 
producers. Most Y. enterocolitica strains harbored 
chromosomal genes blaA and blaB encoding BlaA 
(a non-inducible broad-spectrum carbenicillinase) 
and BlaB (an AmpC-type inducible cephalospori-
nase) [25].  
 In our study, the presence of blaA gene in all 
the strains of biotype 4 and 2 was detected, while 
blaB gene was carried by biotype 2 strains and over 
50% of the biotype 4 strains. These genes were not 
detected in the strains of biotype 1A, although in 
previous studies, in which were used additional 
primers designed using the conserved regions of the 
blaA genes of Y. enterocolitica 8,081, biotype 1B, 
has been shown the presence of this gene in the 
majority of Y. enterocolitica strains of biotype 1A 
[26]. Heterogeneity in blaA gene of Y. enterocolitica 
of biotype 1A was confirmed by Sharma et al. [27]. 
Inability to detect blaA gene in these strains may 
result from a genetic variability in blaA preventing 
the binding of primers. The antimicrobial suscepti-
bility test revealed high resistance of Y. entero-
colitica to antibiotics belonging to penicillin group 
such as ampicillin, ticarcillin and piperacillin. This 
was in accordance with the results obtained by other 
authors [28]. Two strains (9.5%) belonging to 2 and 
4 biotype were also resistant to amoxicillin with 
clavulanic acid, while Frazão et al. [29] showed          
that 19/34 of Y. enterocolitica strains isolated from 
different sources in Brazil were resistant to this 
combination. In our study, all the strains were 
sensitive to the second (cefuroxime), third (cefo-
taxime, ceftazidime, ceftriaxone) and fourth gene-
ration cephalosporins (cefepime), fluoroquinolones 
and imipenem. Fluoroquinolones and the third 
generation cephalosporins are the best therapeutic 
options to treat enterocolitis in compromised hosts 
and in patients with septicemia or invasive infection 
[30]. In case of extra-intestinal yersiniosis, also 
aminoglycosides in combination with other anti-
biotics are used for treatment. In our research, four 
(19%) and six (28.6%) strains were resistant to 
amikacin and gentamicin, respectively. Rusak et al. 
[28] obtained one strain (2%) resistant to amikacin, 
while all the strains were sensitive to gentamicin. In 
Switzerland during 2001-2010 also no gentamicin-
resistant strains were found [4]. Trimethoprim/ 
sulfamethoxazole are also used to treat yersiniosis. 
In this study, four strains (19%) were resistant to 
this sulfonamide. Sporadic resistance to trimetho-
prim/sulfamethoxazole occurred in Switzerland [4], 
while in Brazil trimethoprim/sulfamethoxazole resi-
stance was found in 8.8% to 10% of the strains [28, 
29]. In our study, three strains were multidrug 
resistant. Two strains belonging to biotype 4 showed 
resistance to four different classes of antimicrobial 
agents (penicillins, aminoglycosides, chloramphe-
nicol, sulfonamides and penicillins, aminoglyco-
sides, chloramphenicol, monobactams) and one 
strain of biotype 2 was resistant to antimicrobial 
agents belonging to three groups (penicillins, 
chloramphenicol, sulfonamides). Multiple resistance 
phenotypes were rarely reported in Y. enterocolitica. 
Only one out of from 60 Y. enterocolitica strains 
investigated by Rusak et al. [28] showed resistance 
to the three classes of antimicrobial agents (cephalo-
sporin, sulfonamide, and tetracycline). Fredriksson-
Ahomaa et al. [4] also reported that only one out of 
128 Y. enterocolitica strains isolated from human 
clinical samples in Switzerland showed resistance to 
multiple antimicrobial agents. The multiresistance of 
Y. enterocolitica strains (19%) was found in Finland, 
and these strains were significantly associated with 
traveling abroad [31]. 
Our study showed that Y. enterocolitica 
strains from children in Poland belonging to biotype 
4 and 2 had all investigated virulence genes, 
including the plasmid gene yadA, except the two 
strains of biotype 4 in which this gene was not 
detected. These strains showed high resistance to 
penicillin, although they remain susceptible to drugs 
used for treating gastroenteritidis, as well as extra-
intestinal infections. However, it should be stressed 
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that some strains were resistant to antibiotics used in 
extra-intestinal yersiniosis treatment and few strains 
were multidrug resistant.  
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